Kohnert U, Wozny M, Llinas M, Roos A, Fischer S
Boehringer Mannheim GmbH, Biochemical Research Center Penzberg, Germany.
Appl Biochem Biotechnol. 1995 Nov;55(2):157-66. doi: 10.1007/BF02783556.
BM 06.022 is a tissue-type plasminogen activator deletion variant that is comprised of the kringle 2 and the protease domain of the native molecule. BM 06.022 is expressed as inactive inclusion bodies in E. coli and transferred into the active enzyme by an in vitro folding process. Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone provides evidence that the purified BM 06.022 is fully active and that misfolded species are completely removed by affinity chromatography on ETI-Sepharose. The comparison of the kinetics of the inhibition of BM 06.022 with that of CHO-t-PA indicates that the active centers of both enzymes are rather similar. The further evaluation of the site of interaction of BM 06.022 and DnsEGRck by mass spectroscopy and amino acid sequence analysis revealed that the inhibitor is bound selectively to His322, which is part of the catalytic triad of this serine protease.
BM 06.022是一种组织型纤溶酶原激活剂缺失变体,由天然分子的kringle 2和蛋白酶结构域组成。BM 06.022在大肠杆菌中表达为无活性的包涵体,并通过体外折叠过程转化为活性酶。用丹磺酰谷氨酰甘氨酰精氨酰氯甲基酮进行活性位点标记,证明纯化的BM 06.022具有完全活性,并且通过ETI-琼脂糖亲和层析可完全去除错误折叠的物种。将BM 06.022与CHO-t-PA的抑制动力学进行比较表明,两种酶的活性中心相当相似。通过质谱和氨基酸序列分析对BM 06.022与DnsEGRck相互作用位点的进一步评估表明,抑制剂选择性地结合到His322上,His322是这种丝氨酸蛋白酶催化三联体的一部分。